Non-invasive Imaging of Endothelial Progenitor Cells in Tumor Neovascularization Using a Novel Dual-modality Paramagnetic/Near-Infrared Fluorescence Probe

Objective Bone-marrow derived endothelial progenitor cells (EPCs) play an important role in tumor neovasculature. Due to their tumor homing property, EPCs are regarded as promising targeted vectors for delivering therapeutic agents in cancer treatment. Consequently, non-invasive confirmation of targeted delivery via imaging is urgently needed. This study shows the development and application of a novel dual-modality probe for in vivo non-invasively tracking of the migration, homing and differentiation of EPCs. Methods The paramagnetic/near-infrared fluorescence probe Conjugate 1 labeled EPCs were systemically transplanted into mice bearing human breast MDA-MB-231 tumor xenografts. Magnetic resonance imaging (MRI) and near-infrared (NIR) fluorescence optical imaging were performed at different stages of tumor development. The homing of EPCs and the tumor neovascularization were further evaluated by immunofluorescence. Results Conjugate 1 labeled EPCs can be monitored in vivo by MRI and NIR fluorescence optical imaging without altering tumor growth for up to three weeks after the systemic transplantation. Histopathological examination confirmed that EPCs were recruited into the tumor bed and then incorporated into new vessels two weeks after the transplantation. Tumor size and microvessel density was not influenced by EPCs transplantation in the first three weeks. Conclusions This preclinical study shows the feasibility of using a MRI and NIR fluorescence optical imaging detectable probe to non-invasively monitor transplanted EPCs and also provides strong evidence that EPCs are involved in the development of endothelial cells during the tumor neovascularization.

[1]  A. Arbab,et al.  The Role and Therapeutic Potential of Endothelial Progenitor Cells in Tumor Neovascularization , 2010, TheScientificWorldJournal.

[2]  Jiyang Jin,et al.  In Vivo Magnetic Resonance Imaging of Injected Endothelial Progenitor Cells after Myocardial Infarction in Rats , 2011, Molecular Imaging and Biology.

[3]  S. Gambhir,et al.  Biodistribution of Neural Stem Cells After Intravascular Therapy for Hypoxic–Ischemia , 2010, Stroke.

[4]  H. Tsukada,et al.  In vivo trafficking of endothelial progenitor cells their possible involvement in the tumor neovascularization. , 2004, Life sciences.

[5]  Dai Fukumura,et al.  Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. , 2008, Blood.

[6]  Z. Bhujwalla,et al.  Conjugation of poly-L-lysine to bacterial cytosine deaminase improves the efficacy of enzyme/prodrug cancer therapy. , 2008, Journal of medicinal chemistry.

[7]  Dai Fukumura,et al.  Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. , 2007, Microvascular research.

[8]  I. Weissman,et al.  Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth , 2008, Proceedings of the National Academy of Sciences.

[9]  J. Frangioni,et al.  Image-Guided Surgery Using Invisible Near-Infrared Light: Fundamentals of Clinical Translation , 2010, Molecular imaging.

[10]  S Sone,et al.  Growth rate of small lung cancers detected on mass CT screening. , 2000, The British journal of radiology.

[11]  B. Peters,et al.  Contribution of bone marrow–derived endothelial cells to human tumor vasculature , 2005, Nature Medicine.

[12]  J A Frank,et al.  Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  N. Altorki,et al.  Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. , 2009, Biochimica et biophysica acta.

[14]  H. Fine,et al.  Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors , 2003, Gene Therapy.

[15]  Z. Bhujwalla,et al.  Image-Guided Enzyme/Prodrug Cancer Therapy , 2008, Clinical Cancer Research.

[16]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[17]  Lei Xu,et al.  Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. , 2004, Cancer cell.

[18]  B. Teicher,et al.  Pericytes and endothelial precursor cells: cellular interactions and contributions to malignancy. , 2005, Cancer research.

[19]  Xiaoyuan Chen,et al.  Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers. , 2010, Molecular imaging.

[20]  Hisataka Kobayashi,et al.  In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. , 2009, Cancer research.

[21]  B. Stoddard,et al.  Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy. , 2004, Protein engineering, design & selection : PEDS.

[22]  Y. Ni,et al.  Multimodality Imaging of Endothelial Progenitor Cells with a Novel Multifunctional Probe Featuring Positive Magnetic Resonance Contrast and Near-Infrared Fluorescence , 2011, Molecular imaging.

[23]  Victor Frenkel,et al.  Magnetic Resonance Imaging and Confocal Microscopy Studies of Magnetically Labeled Endothelial Progenitor Cells Trafficking to Sites of Tumor Angiogenesis , 2006, Stem cells.

[24]  Fan Wang,et al.  Optical Imaging of Integrin αvβ3 Expression with Near-Infrared Fluorescent RGD Dimer with Tetra(ethylene glycol) Linkers , 2010 .

[25]  R. Jain.  Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[26]  Peter van Gelderen,et al.  Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.

[27]  Toyoaki Murohara,et al.  Derivation of Functional Endothelial Progenitor Cells from Human Umbilical Cord Blood Mononuclear Cells Isolated by a Novel Cell Filtration Device , 2004, Stem cells.

[28]  S. Rafii,et al.  Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.

[29]  Zhan-Long Ma,et al.  Assessments of Proliferation Capacity and Viability of New Zealand Rabbit Peripheral Blood Endothelial Progenitor Cells Labeled with Superparamagnetic Particles , 2009, Cell transplantation.

[30]  J. Tímár,et al.  Circulating bone marrow‐derived endothelial progenitor cells: Characterization, mobilization, and therapeutic considerations in malignant disease , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[31]  P. Hamilton,et al.  Non-Invasive in vivo Imaging in Small Animal Research , 2006, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[32]  Christie M. Orschell,et al.  Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors , 2003, Circulation.

[33]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[34]  R. Weissleder,et al.  Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging , 2002, European Radiology.

[35]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[36]  Tao-Sheng Li,et al.  Inhibition of accelerated tumor growth by blocking the recruitment of mobilized endothelial progenitor cells after chemotherapy , 2009, International journal of cancer.

[37]  D. Scheinberg,et al.  Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. , 2007, Genes & development.

[38]  M. Modo,et al.  Use of a Clinically Approved Iron Oxide MRI Contrast Agent to Label Human Hepatocytes , 2011, Cell transplantation.

[39]  H. Soltanian-Zadeh,et al.  Endothelial Progenitor Cells (EPCs) as Gene Carrier System for Rat Model of Human Glioma , 2012, PloS one.

[40]  R. Knight,et al.  AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study , 2009, BMC biotechnology.

[41]  Ricky T. Tong,et al.  Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. , 2007, Cancer research.